# Evaluating the Association Between Sphingolipid Metabolites and Post-hepatectomy Liver Failure

> **NCT03598465** · — · COMPLETED · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 591 (actual)

## Conditions studied

- Post-hepatectomy Liver Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03598465
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-05
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-10-01
- **Target enrollment:** 591 (ACTUAL)
- **Last updated:** 2024-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03598465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03598465, "Evaluating the Association Between Sphingolipid Metabolites and Post-hepatectomy Liver Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03598465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*